Effects of realgar (As4S4) on degradation of PML-RARA harboring acquired arsenic-resistance mutations

被引：6
作者：
Niu, Mingshan [1 ,2 ]
Shen, Yangling [1 ]
Qi, Jialei [1 ]
Liu, Xuejiao [3 ]
Sang, Wei [2 ]
Wu, Qingyun [1 ]
Cao, Jiang [2 ]
Chen, Wei [2 ]
Yao, Yao [1 ]
Xu, Kailin [1 ,2 ]
机构：
[1] Xuzhou Med Univ, Blood Dis Inst, Jiangsu Key Lab Bone Marrow Stem Cell, Xuzhou, Jiangsu, Peoples R China
[2] Xuzhou Med Univ, Affiliated Hosp, Dept Hematol, Xuzhou, Jiangsu, Peoples R China
[3] Xuzhou Med Univ, Insititute Nervous Syst Dis, Xuzhou, Jiangsu, Peoples R China
来源：
ANNALS OF HEMATOLOGY | 2017年 / 96卷 / 11期
基金：
中国博士后科学基金; 中国国家自然科学基金;
关键词：
ACUTE PROMYELOCYTIC LEUKEMIA; ACUTE MYELOID-LEUKEMIA; TRIOXIDE; MULTICENTER; THERAPY;
D O I：
10.1007/s00277-017-3093-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1945 / 1948
页数：4
相关论文
共 10 条
  • [1] Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia
    Feldman, EJ
    Brandwein, J
    Stone, R
    Kalaycio, M
    Moore, J
    O'Connor, J
    Wedel, N
    Roboz, GJ
    Miller, C
    Chopra, R
    Jurcic, JC
    Brown, R
    Ehmann, WC
    Schulman, P
    Frankel, SR
    De Angelo, D
    Scheinberg, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (18) : 4110 - 4116
  • [2] PML/RARA Oxidation and Arsenic Binding Initiate the Antileukemia Response of As2O3
    Jeanne, Marion
    Lallemand-Breitenbach, Valerie
    Ferhi, Omar
    Koken, Marcel
    Le Bras, Morgane
    Duffort, Stephanie
    Peres, Laurent
    Berthier, Caroline
    Soilihi, Hassane
    Raught, Brian
    de The, Hugues
    [J]. CANCER CELL, 2010, 18 (01) : 88 - 98
  • [3] Arsenic degrades PML or PML - RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway
    Lallemand-Breitenbach, Valerie
    Jeanne, Marion
    Benhenda, Shirine
    Nasr, Rihab
    Lei, Ming
    Peres, Laurent
    Zhou, Jun
    Zhu, Jun
    Raught, Brian
    de The, Hugues
    [J]. NATURE CELL BIOLOGY, 2008, 10 (05) : 547 - 555
  • [4] Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
    Lo-Coco, F.
    Avvisati, G.
    Vignetti, M.
    Thiede, C.
    Orlando, S. M.
    Iacobelli, S.
    Ferrara, F.
    Fazi, P.
    Cicconi, L.
    Di Bona, E.
    Specchia, G.
    Sica, S.
    Divona, M.
    Levis, A.
    Fiedler, W.
    Cerqui, E.
    Breccia, M.
    Fioritoni, G.
    Salih, H. R.
    Cazzola, M.
    Melillo, L.
    Carella, A. M.
    Brandts, C. H.
    Morra, E.
    von Lilienfeld-Toal, M.
    Hertenstein, B.
    Wattad, M.
    Luebbert, M.
    Haenel, M.
    Schmitz, N.
    Link, H.
    Kropp, M. G.
    Rambaldi, A.
    La Nasa, G.
    Luppi, M.
    Ciceri, F.
    Finizio, O.
    Venditti, A.
    Fabbiano, F.
    Doehner, K.
    Sauer, M.
    Ganser, A.
    Amadori, S.
    Mandelli, F.
    Doehner, H.
    Ehninger, G.
    Schlenk, R. F.
    Platzbecker, U.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (02) : 111 - 121
  • [5] Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients
    Lou, Yinjun
    Ma, Yafang
    Sun, Jianai
    Ye, Xiujin
    Pan, Hanzhang
    Wang, Yungui
    Qian, Wenbin
    Meng, Haitao
    Mai, Wenyuan
    He, JingSong
    Tong, Hongyan
    Jin, Jie
    [J]. ANNALS OF HEMATOLOGY, 2015, 94 (11) : 1829 - 1837
  • [6] Acute Myeloid Leukemia, Version 2.2013 Featured Updates to the NCCN Guidelines
    O'Donnell, Margaret R.
    Tallman, Martin S.
    Abboud, Camille N.
    Altman, Jessica K.
    Appelbaum, Frederick R.
    Arber, Daniel A.
    Attar, Eyal
    Borate, Uma
    Coutre, Steven E.
    Damon, Lloyd E.
    Lancet, Jeffrey
    Maness, Lori J.
    Marcucci, Guido
    Martin, Michael G.
    Millenson, Michael M.
    Moore, Joseph O.
    Ravandi, Farhad
    Shami, Paul J.
    Smith, B. Douglas
    Stone, Richard M.
    Strickland, Stephen A.
    Wang, Eunice S.
    Gregory, Kristina M.
    Naganuma, Maoko
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (09): : 1047 - 1055
  • [7] Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation
    Schmid, Christoph
    Labopin, Myriam
    Nagler, Arnon
    Niederwieser, Dietger
    Castagna, Luca
    Tabrizi, Reza
    Stadler, Michael
    Kuball, Juergen
    Cornelissen, Jan
    Vorlicek, Jiri
    Socie, Gerard
    Falda, Michele
    Vindelov, Lars
    Ljungman, Per
    Jackson, Graham
    Kroeger, Nicolaus
    Rank, Andreas
    Polge, Emmanuelle
    Rocha, Vanderson
    Mohty, Mohamad
    [J]. BLOOD, 2012, 119 (06) : 1599 - 1606
  • [8] Overexpression of the long non-coding RNA PVT1 is correlated with leukemic cell proliferation in acute promyelocytic leukemia
    Zeng, Chengwu
    Yu, Xibao
    Lai, Jing
    Yang, Lijiang
    Chen, Shaohua
    Li, Yangqiu
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2015, 8
  • [9] Resistance to Arsenic Therapy in Acute Promyelocytic Leukemia
    Zhu, Hong-Hu
    Qin, Ya-Zhen
    Huang, Xiao-Jun
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (19) : 1864 - 1866
  • [10] Oral Tetra-Arsenic Tetra-Sulfide Formula Versus Intravenous Arsenic Trioxide As First-Line Treatment of Acute Promyelocytic Leukemia: A Multicenter Randomized Controlled Trial
    Zhu, Hong-Hu
    Wu, De-Pei
    Jin, Jie
    Li, Jian-Yong
    Ma, Jun
    Wang, Jian-Xiang
    Jiang, Hao
    Chen, Sai-Juan
    Huang, Xiao-Jun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (33) : 4215 - +
1